Antimicrobial Susceptibility Testing Market by Product (Manual (Disk, Strip, Plate), Automated, Molecular), Method (E-Test, Disk & Agar Diffusion, Genotypic), Type (Antibacterial, Antifungal), Application (Clinical, Epidemiology) Global Forecasts to 2029

1.1 Study Objectives
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Inclusions and Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Stakeholders
1.5 Summary of Changes

2.1 Research Data
2.2 Research Design
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.2.1 Primary Sources
2.2.2.2 Key Industry Insights
2.2.2.3 Breakdown of Primaries
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.1.1 Approach 1: Company Revenue Estimation Approach
2.3.1.2 Approach 2: Customer-based Market Estimation
2.3.1.3 Approach 3: Top-Down Approach
2.3.1.4 Approach 4: Primary Interviews
2.3.1.5 CAGR Projections
2.4 Data Triangulation & Market Breakdown
2.5 Market Share Assessment
2.6 Study Assumptions
2.7 Assumptions/Market Forecasting Methodology
2.8 Limitations and Risk Assessment

4.1 Antimicrobial Susceptibility Testing Market Overview
4.2 Antimicrobial Susceptibility Testing Market, By Region, 2024 vs. 2029 (USD Million)
4.3 Antimicrobial Susceptibility Testing Market, By Region and End-user, 2023 (USD Million)
4.4 Geographic Growth Opportunities in Antimicrobial Susceptibility Testing Market

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Antimicrobial Resistance
5.2.1.2 Advancements in Diagnostic Technologies
5.2.1.3 Expansion of Clinical Research Applications
5.2.1.4 Rise in Government Initiatives
5.2.2 Restraints
5.2.2.1 High Cost of Automated Instruments
5.2.3 Opportunities
5.2.3.1 Emergence of Rapid Testing Solutions
5.2.3.2 Integration with Digital Health Technologies
5.2.4 Challenges
5.2.4.1 Intricate Regulatory Landscape
5.3 Industry Trends
5.3.1 Isothermal Microcalorimetry
5.3.2 Fluorescence-Activated Cell Sorting
5.3.3 Smartphone-based Optical Spectroscopy
5.3.4 Microfluidics and Microdroplets
5.4 Ecosystem Analysis
5.5 Supply Chain Analysis
5.5.1 Prominent Companies
5.5.2 Small and Medium-Sized Enterprises
5.5.3 End-users
5.6 Value Chain Analysis
5.7 Porter's Five Forces Analysis
5.7.1 Threat of New Entrants
5.7.2 Bargaining Power of Suppliers
5.7.3 Bargaining Power of Buyers
5.7.4 Threat of Substitutes
5.7.5 Intensity of Competitive Rivalry
5.8 Key Stakeholders and Buying Criteria
5.8.1 Key Stakeholders in Buying Process
5.8.2 Buying Criteria
5.9 Patent Analysis
5.10 Trade Analysis
5.10.1 Import Data
5.10.2 Export Data
5.11 Key Conferences and Events, 2024-2025
5.12 Trends/Disruptions Impacting Customers’ Businesses
5.13 Technology Analysis
5.13.1 Key Technologies
5.13.1.1 Pcr
5.13.1.2 Microfluidics and Lab-On-A-Chip
5.13.1.3 Synthetic Antimicrobial Peptides
5.13.2 Complimentary Technologies
5.13.2.1 Maldi-Tof
5.13.3 Adjacent Technologies
5.13.3.1 Nanotechnology
5.13.3.2 Nanomotion Technology
5.13.3.3 Biochip Technology
5.14 Regulatory Landscape
5.14.1 North America
5.14.1.1 US
5.14.1.2 Canada
5.14.2 Europe
5.14.3 Asia-Pacific
5.14.3.1 Japan
5.14.3.2 China
5.14.3.3 India
5.14.4 Regulatory Bodies, Government Agencies, And Other Organizations
5.15 Investment and Funding Scenario
5.16 Pricing Analysis
5.16.1 Average Selling Price, by Region
5.16.2 Average Selling Price, by Key Player
5.17 Reimbursement Scenario
5.18 Unmet Needs and Key Pain Points
5.19 Impact of AI/Gen AI on Antimicrobial Susceptibility Testing Market

6.1 Introduction
6.2 Consumables
6.2.1 Culture & Growth Media
6.2.1.1 High Utilization of Disk Diffusion and Broth Dilution Methods To Drive Market
6.2.2 Susceptibility Testing Disks
6.2.2.1 Low Costs, Ease of Use to Support Adoption
6.2.3 Mic Strips
6.2.3.1 Accuracy, Simplicity, and Thorough Results to Drive Usage
6.2.4 Susceptibility Testing Plates
6.2.4.1 Availability of Specialized Plates to Drive Market
6.3 Lab Instruments
6.3.1 Automated Laboratory Instruments
6.3.1.1 Ongoing Trend of Laboratory Automation to Fuel Segment Growth
6.3.2 Molecular Diagnostics Systems
6.3.2.1 Technological Advancements in Molecular Diagnostics To Propel Market
6.4 Lab Disposables
6.4.1 Increasing Number of Susceptibility Tests Performed in Hospitals to Drive Demand

7.1 Introduction
7.2 Antibacterial Susceptibility Testing
7.2.1 Emergence of Multidrug-Resistance to Increase Adoption of Antibacterial Susceptibility Testing Products
7.3 Antifungal Susceptibility Testing
7.3.1 Increasing Prevalence of Infectious Diseases to Propel Demand for Testing
7.4 Antiparasitic Susceptibility Testing
7.4.1 Rising Awareness to Support Market Growth
7.5 Antiviral Susceptibility Testing
7.5.1 Advancements in Antiviral Susceptibility Testing to Enhance Patient Outcomes

8.1 Introduction
8.2 Qualitative Methods
8.2.1 Automated Ast
8.2.1.1 Advancements and Resistance Patterns to Drive Use of Automated Instruments
8.2.2 Disk Diffusion
8.2.2.1 Simplicity, Accuracy, and Flexibility to Support Adoption
8.2.3 Agar Dilution
8.2.3.1 Time-Consuming and Labor-Intensive Nature to Affect Adoption
8.2.4 Genotypic Method
8.2.4.1 Gold Standard Status to Support Greater Adoption
8.3 Quantitative Methods
8.3.1 Etest Method
8.3.1.1 Etest to Hold Larger Share of Quantitative Methods Market
8.3.2 Broth Macrodilution
8.3.2.1 Precision, Simultaneous Testing Capability to Drive Market

9.1 Introduction
9.2 Clinical Diagnostics
9.2.1 Technological Advancements to Drive Market
9.3 Drug Discovery & Development
9.3.1 Emphasis on R&D and Innovation to Support Demand Growth
9.4 Epidemiology
9.4.1 Need for Better Understanding and Decision Making to Propel Adoption
9.5 Other Applications

10.1 Introduction
10.2 Hospitals & Diagnostic Centers
10.2.1 Hospitals & Diagnostic Centers to Hold Largest Market Share
10.3 Pharmaceutical & Biotechnology Companies
10.3.1 Emphasis on Product Development to Drive Market
10.4 Academic & Research Institutes
10.4.1 Rising R&D Activity and Support for Research to Drive Market
10.5 Clinical Research Organizations
10.5.1 Expansion of Clinical Trials Worldwide to Propel Market Growth

11.1 Introduction
11.2 North America
11.2.1 North America: Macroeconomic Outlook
11.2.2 US
11.2.2.1 US to Hold Largest Share of North American Market
11.2.3 Canada
11.2.3.1 Favorable Government Initiatives to Drive Market Growth
11.3 Europe
11.3.1 Europe: Macroeconomic Outlook
11.3.2 Germany
11.3.2.1 Government Initiatives for Amr to Drive Market
11.3.3 France
11.3.3.1 Focus on Enhancing Amr Surveillance to Propel Market
11.3.4 UK
11.3.4.1 New Action Plans for Amr to Propel Adoption
11.3.5 Italy
11.3.5.1 Rising Instances of Amr and High Use of Antibiotics to Propel Demand for Testing
11.3.6 Spain
11.3.6.1 Rising Amr in Gram-Negative Bacilli to Drive Market
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Asia-Pacific: Macroeconomic Outlook
11.4.2 Japan
11.4.2.1 Industry-Government Collaborations for Infectious Disease Management to Support Market Growth
11.4.3 China
11.4.3.1 Rising Emphasis on Amr Management to Drive Market
11.4.4 India
11.4.4.1 Expanding Government and Industry Efforts in Clinical Diagnostics to Propel Market Growth
11.4.5 Australia
11.4.5.1 Establishment and Implementation of Antimicrobial Treatment Guidelines to Favor Market Growth
11.4.6 South Korea
11.4.6.1 Need for Rapid Amr Detection to Drive Demand for Automated Ast Systems
11.4.7 Rest of Asia-Pacific
11.5 Latin America
11.5.1 Latin America: Macroeconomic Outlook
11.5.2 Brazil
11.5.2.1 Rising Emphasis on Implementing Amr Detection to Drive Market
11.5.3 Mexico
11.5.3.1 Economic Growth to Support Expansion of Ast Systems
11.5.4 Rest of Latin America
11.6 Middle East & Africa
11.6.1 Middle East & Africa: Macroeconomic Outlook
11.6.2 GCC Countries
11.6.2.1 Healthcare Infrastructural Development Initiatives to Support Growth
11.6.3 Rest of Middle East & Africa

12.1 Overview
12.2 Key Player Strategies/Right to Win
12.2.1 Overview of Strategies Adopted by Players in Antimicrobial Susceptibility Testing Market
12.3 Revenue Analysis
12.4 Market Share Analysis, 2023
12.5 Company Evaluation Matrix: Key Players, 2023
12.5.1 Stars
12.5.2 Emerging Leaders
12.5.3 Pervasive Players
12.5.4 Participants
12.5.5 Company Footprint: Key Players, 2023
12.5.5.1 Company Footprint
12.5.5.2 Region Footprint
12.5.5.3 Product Footprint
12.5.5.4 Type Footprint
12.5.5.5 Method Footprint
12.5.5.6 Application Footprint
12.5.5.7 End-user Footprint
12.6 Company Evaluation Matrix: Startups/SMEs, 2023
12.6.1 Progressive Companies
12.6.2 Responsive Companies
12.6.3 Dynamic Companies
12.6.4 Starting Blocks
12.6.5 Competitive Benchmarking: Startups/SMEs, 2023
12.7 Valuation & Financial Metrics
12.7.1 Financial Metrics
12.7.2 Company Valuation
12.8 Brand/Product Comparison
12.9 Competitive Scenario
12.9.1 Product Launches & Approvals
12.9.2 Deals

13.1 Key Players
13.1.1 bioMérieux SA
13.1.1.1 Business Overview
13.1.1.2 Products Offered
13.1.1.3 Recent Developments
13.1.1.3.1 Product Launches & Approvals
13.1.1.3.2 Deals
13.1.1.4 Analyst's View
13.1.1.4.1 Right to Win
13.1.1.4.2 Strategic Choices
13.1.1.4.3 Weaknesses & Competitive Threats
13.1.2 Becton, Dickinson and Company
13.1.2.1 Business Overview
13.1.2.2 Products Offered
13.1.2.3 Recent Developments
13.1.2.3.1 Deals
13.1.2.3.2 Other Developments
13.1.2.4 Analyst's View
13.1.2.4.1 Right to Win
13.1.2.4.2 Strategic Choices
13.1.2.4.3 Weaknesses and Competitive Threats
13.1.3 Thermo Fisher Scientific Inc.
13.1.3.1 Business Overview
13.1.3.2 Products Offered
13.1.3.3 Recent Developments
13.1.3.3.1 Product Launches & Approvals
13.1.3.3.2 Deals
13.1.3.4 Analyst's View
13.1.3.4.1 Right to Win
13.1.3.4.2 Strategic Choices
13.1.3.4.3 Weaknesses and Competitive Threats
13.1.4 Danaher Corporation
13.1.4.1 Business Overview
13.1.4.2 Products Offered
13.1.4.3 Recent Developments
13.1.4.3.1 Product Launches & Approvals
13.1.4.3.2 Deals
13.1.4.4 Analyst's View
13.1.4.4.1 Right to Win
13.1.4.4.2 Strategic Choices
13.1.4.4.3 Weaknesses and Competitive Threats
13.1.5 Bio-Rad Laboratories, Inc.
13.1.5.1 Business Overview
13.1.5.2 Products Offered
13.1.5.2.1 Deals
13.1.5.3 Analyst's View
13.1.5.3.1 Right to Win
13.1.5.3.2 Strategic Choices
13.1.5.3.3 Weaknesses and Competitive Threats
13.1.6 Bruker
13.1.6.1 Business Overview
13.1.6.2 Products Offered
13.1.6.3 Recent Developments
13.1.6.3.1 Product Launches & Approvals
13.1.6.3.2 Deals
13.1.7 Roche Diagnostics
13.1.7.1 Business Overview
13.1.7.2 Products Offered
13.1.7.3 Recent Developments
13.1.7.3.1 Product Launches & Approvals
13.1.7.3.2 Deals
13.1.8 Merck KGaA
13.1.8.1 Business Overview
13.1.8.2 Products Offered
13.1.8.3 Recent Developments
13.1.8.3.1 Deals
13.1.9 Accelerate Diagnostics, Inc.
13.1.9.1 Business Overview
13.1.9.2 Products Offered
13.1.9.3 Recent Developments
13.1.9.3.1 Product Launches & Approvals
13.1.9.3.2 Deals
13.1.9.3.3 Other Developments
13.1.10 Himedia Laboratories
13.1.10.1 Business Overview
13.1.10.2 Products Offered
13.1.11 Liofilchem S.R.L.
13.1.11.1 Business Overview
13.1.11.2 Products Offered
13.1.12 Alifax S.R.L.
13.1.12.1 Business Overview
13.1.12.2 Products Offered
13.1.13 Creative Diagnostics
13.1.13.1 Business Overview
13.1.13.2 Products Offered
13.1.14 Synbiosis
13.1.14.1 Business Overview
13.1.14.2 Products Offered
13.1.15 Bioanalyse
13.1.15.1 Business Overview
13.1.15.2 Products Offered
13.2 Other Key Players
13.2.1 Zhuhai Dl Biotech Co. Ltd.
13.2.2 Elitechgroup
13.2.3 Mast Group Ltd.
13.2.4 Condalab
13.2.5 Genefluidics, Inc.
13.2.6 Biotron Healthcare
13.2.7 Invivogen
13.2.8 Mp Biomedicals
13.2.9 Quantamatrix Inc.
13.2.10 Sysmex Europe SE
13.2.11 Copan Diagnostics Inc.
13.2.12 Erba Diagnostics Mannheim GmbH

14.1 Discussion Guide
14.2 Knowledgestore: The Subscription Portal
14.3 Customization Options

Table 1 Antimicrobial Susceptibility Testingmarket: Inclusions & Exclusions
Table 2 Limitations and Associated Risks
Table 3 Mitigation of Antimicrobial Resistance
Table 4 Comparison of Antimicrobial Susceptibility Testing Automated Product Pricing
Table 5 Discrepancies Between Fda-Approved Ast Criteria and Cdc-Identified Antimicrobial Resistance Threats
Table 6 Antimicrobial Susceptibility Testing Market: Role of Companies In Ecosystem
Table 7 Antimicrobial Susceptibility Testing Market: Impact of Porter's Five Forces
Table 8 Influence of Stakeholders on Buying Process for Top Four End-users (%)
Table 9 Key Buying Criteria, by End-user
Table 10 List of Major Patent Innovations and Patent Registrations, 2022-2024
Table 11 Import Data for HS Code 3822, by Country, 2019-2023 (USD Thousand)
Table 12 Export Data for HS Code 3822, by Country, 2019-2023 (USD Thousand)
Table 13 Antimicrobial Susceptibility Testing Market: Detailed List of Conferences and Events
Table 14 US Fda: Medical Device Classification
Table 15 US: Medical Device Regulatory Approval Process
Table 16 Canada: Medical Device Regulatory Approval Process
Table 17 Japan: Medical Device Classification Under Pharmaceuticals And Medical Devices Agency
Table 18 China: Classification of Medical Devices
Table 19 North America: List of Regulatory Bodies, Government Agencies, And Other Organizations
Table 20 Europe: List of Regulatory Bodies, Government Agencies, And Other Organizations
Table 21 Asia-Pacific: List of Regulatory Bodies, Government Agencies, And Other Organizations
Table 22 Latin America: List of Regulatory Bodies, Government Agencies, And Other Organizations
Table 23 Rest of the World: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 24 Average Selling Price of Ast Products, by Region, 2021-2023 (USD Thousand)
Table 25 Average Selling Price of Top 3 Applications, by Key Player, 2023 (USD)
Table 26 US: Major Cpt Codes Associated with Ast, 2023
Table 27 Antimicrobial Susceptibility Testing Market: Current Unmet Needs
Table 28 Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 29 Antimicrobial Susceptibility Testing Consumables Market, By Type, 2022-2029 (USD Million)
Table 30 Antimicrobial Susceptibility Testing Consumables Market, By Region, 2022-2029 (USD Million)
Table 31 Culture & Growth Media Market, by Region, 2022-2029 (USD Million)
Table 32 Susceptibility Testing Disks Market, by Region, 2022-2029 (USD Million)
Table 33 Mic Strips Market, by Region, 2022-2029 (USD Million)
Table 34 Susceptibility Testing Plates Market, by Region, 2022-2029 (USD Million)
Table 35 Antimicrobial Susceptibility Testing Lab Instruments Market, By Type, 2022-2029 (USD Million)
Table 36 Antimicrobial Susceptibility Testing Lab Instruments Market, By Region, 2022-2029 (USD Million)
Table 37 Automated Laboratory Instruments Market, By Region, 2022-2029 (USD Million)
Table 38 Molecular Diagnostics Systems Market, By Region, 2022-2029 (USD Million)
Table 39 Lab Disposables Market, by Region, 2022-2029 (USD Million)
Table 40 Antimicrobial Susceptibility Testing Market, By Type, 2022-2029 (USD Million)
Table 41 Antibacterial Susceptibility Testing Market, By Region, 2022-2029 (USD Million)
Table 42 US: Deaths from Fungal Diseases, 2021
Table 43 Antifungal Susceptibility Testing Market, By Region, 2022-2029 (USD Million)
Table 44 Antiparasitic Susceptibility Testing Market, By Region, 2022-2029 (USD Million)
Table 45 Antiviral Susceptibility Testing Market, By Region, 2022-2029 (USD Million)
Table 46 Antimicrobial Susceptibility Testing Market, By Method, 2022-2029 (USD Million)
Table 47 Qualitative Antimicrobial Susceptibility Testing Methods Market, By Type, 2022-2029 (USD Million)
Table 48 Qualitative Antimicrobial Susceptibility Testing Methods Market, By Region, 2022-2029 (USD Million)
Table 49 Available and Emerging Automated Ast Technologies
Table 50 Automated Antimicrobial Susceptibility Testing Market, By Region, 2022-2029 (USD Million)
Table 51 Antimicrobial Susceptibility Testing Market for Disk Diffusion, By Region, 2022-2029 (USD Million)
Table 52 Antimicrobial Susceptibility Testing Market for Agar Dilution, By Region, 2022-2029 (USD Million)
Table 53 Antimicrobial Susceptibility Testing Market for Genotypic Method, By Region, 2022-2029 (USD Million)
Table 54 Quantitative Antimicrobial Susceptibility Testing Methods Market, By Type, 2022-2029 (USD Million)
Table 55 Quantitative Antimicrobial Susceptibility Testing Methods Market, By Region, 2022-2029 (USD Million)
Table 56 Antimicrobial Susceptibility Testing Market for Etest Method, By Region, 2022-2029 (USD Million)
Table 57 Antimicrobial Susceptibility Testing Market For Broth Macrodilution, by Region, 2022-2029 (USD Million)
Table 58 Antimicrobial Susceptibility Testing Market, By Application, 2022-2029 (USD Million)
Table 59 Antimicrobial Susceptibility Testing Market for Clinical Diagnostics, by Region, 2022-2029 (USD Million)
Table 60 Antimicrobial Susceptibility Testing Market for Drug Discovery & Development, by Region, 2022-2029 (USD Million)
Table 61 Antimicrobial Susceptibility Testing Market for Epidemiology, By Region, 2022-2029 (USD Million)
Table 62 Antimicrobial Susceptibility Testing Market for Other Applications, By Region, 2022-2029 (USD Million)
Table 63 Antimicrobial Susceptibility Testing Market, By End-user, 2022-2029 (USD Million)
Table 64 Antimicrobial Susceptibility Testing Market for Hospitals & Diagnostic Centers, by Region, 2022-2029 (USD Million)
Table 65 Antimicrobial Susceptibility Testing Market for Pharmaceutical & Biotechnology Companies, by Region, 2022-2029 (USD Million)
Table 66 Antimicrobial Susceptibility Testing Market for Academic & Research Institutes, by Region, 2022-2029 (USD Million)
Table 67 Antimicrobial Susceptibility Testing Market for Clinical Research Organizations, by Region, 2022-2029 (USD Million)
Table 68 Antimicrobial Susceptibility Testing Market, by Region, 2022-2029 (USD Million)
Table 69 North America: Macroindicators
Table 70 North America: Antimicrobial Susceptibility Testing Market, By Country, 2022-2029 (USD Million)
Table 71 North America: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 72 North America: Antimicrobial Susceptibility Testing Consumables Market, by Type, 2022-2029 (USD Million)
Table 73 North America: Antimicrobial Susceptibility Testing Lab Instruments Market, by Type, 2022-2029 (USD Million)
Table 74 North America: Antimicrobial Susceptibility Testing Market, By Type, 2022-2029 (USD Million)
Table 75 North America: Antimicrobial Susceptibility Testing Market, By Application, 2022-2029 (USD Million)
Table 76 North America: Antimicrobial Susceptibility Testing Market, By Method, 2022-2029 (USD Million)
Table 77 North America: Qualitative Antimicrobial Susceptibility Testing Methods Market, by Type, 2022-2029 (USD Million)
Table 78 North America: Quantitative Antimicrobial Susceptibility Testing Methods Market, by Type, 2022-2029 (USD Million)
Table 79 North America: Antimicrobial Susceptibility Testing Market, By End-user, 2022-2029 (USD Million)
Table 80 US: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 81 US: Antimicrobial Susceptibility Testing Consumables Market, By Type, 2022-2029 (USD Million)
Table 82 US: Antimicrobial Susceptibility Testing Lab Instruments Market, By Type, 2022-2029 (USD Million)
Table 83 Canada: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 84 Canada: Antimicrobial Susceptibility Testing Consumables Market, By Type, 2022-2029 (USD Million)
Table 85 Canada: Antimicrobial Susceptibility Testing Lab Instruments Market, by Type, 2022-2029 (USD Million)
Table 86 Europe: Macroindicators
Table 87 Europe: Antimicrobial Susceptibility Testing Market, By Country, 2022-2029 (USD Million)
Table 88 Europe: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 89 Europe: Antimicrobial Susceptibility Testing Consumables Market, By Type, 2022-2029 (USD Million)
Table 90 Europe: Antimicrobial Susceptibility Testing Lab Instruments Market, by Type, 2022-2029 (USD Million)
Table 91 Europe: Antimicrobial Susceptibility Testing Market, By Type, 2022-2029 (USD Million)
Table 92 Europe: Antimicrobial Susceptibility Testing Market, By Application, 2022-2029 (USD Million)
Table 93 Europe: Antimicrobial Susceptibility Testing Market, By Method, 2022-2029 (USD Million)
Table 94 Europe: Qualitative Antimicrobial Susceptibility Testing Methods Market, by Type, 2022-2029 (USD Million)
Table 95 Europe: Quantitative Antimicrobial Susceptibility Testing Methods Market, by Type, 2022-2029 (USD Million)
Table 96 Europe: Antimicrobial Susceptibility Testing Market, By End-user, 2022-2029 (USD Million)
Table 97 Germany: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 98 Germany: Antimicrobial Susceptibility Testing Consumables Market, By Type, 2022-2029 (USD Million)
Table 99 Germany: Antimicrobial Susceptibility Testing Lab Instruments Market, by Type, 2022-2029 (USD Million)
Table 100 France: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 101 France: Antimicrobial Susceptibility Testing Consumables Market, By Type, 2022-2029 (USD Million)
Table 102 France: Antimicrobial Susceptibility Testing Lab Instruments Market, by Type, 2022-2029 (USD Million)
Table 103 UK: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 104 UK: Antimicrobial Susceptibility Testing Consumables Market, By Type, 2022-2029 (USD Million)
Table 105 UK: Antimicrobial Susceptibility Testing Lab Instruments Market, By Type, 2022-2029 (USD Million)
Table 106 Italy: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 107 Italy: Antimicrobial Susceptibility Testing Consumables Market, By Type, 2022-2029 (USD Million)
Table 108 Italy: Antimicrobial Susceptibility Testing Lab Instruments Market, By Type, 2022-2029 (USD Million)
Table 109 Spain: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 110 Spain: Antimicrobial Susceptibility Testing Consumables Market, By Type, 2022-2029 (USD Million)
Table 111 Spain: Antimicrobial Susceptibility Testing Lab Instruments Market, By Type, 2022-2029 (USD Million)
Table 112 Rest of Europe: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 113 Rest of Europe: Antimicrobial Susceptibility Testing Consumables Market, by Type, 2022-2029 (USD Million)
Table 114 Rest of Europe: Antimicrobial Susceptibility Testing Lab Instruments Market, by Type, 2022-2029 (USD Million)
Table 115 Asia-Pacific: Macroindicators
Table 116 Asia-Pacific: Antimicrobial Susceptibility Testing Market, By Country, 2022-2029 (USD Million)
Table 117 Asia-Pacific: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 118 Asia-Pacific: Antimicrobial Susceptibility Testing Consumables Market, by Type, 2022-2029 (USD Million)
Table 119 Asia-Pacific: Antimicrobial Susceptibility Testing Lab Instruments Market, by Type, 2022-2029 (USD Million)
Table 120 Asia-Pacific: Antimicrobial Susceptibility Testing Market, By Type, 2022-2029 (USD Million)
Table 121 Asia-Pacific: Antimicrobial Susceptibility Testing Market, By Application, 2022-2029 (USD Million)
Table 122 Asia-Pacific: Antimicrobial Susceptibility Testing Market, By Method, 2022-2029 (USD Million)
Table 123 Asia-Pacific: Qualitative Antimicrobial Susceptibility Testing Methods Market, by Type, 2022-2029 (USD Million)
Table 124 Asia-Pacific: Quantitative Antimicrobial Susceptibility Testing Methods Market, by Type, 2022-2029 (USD Million)
Table 125 Asia-Pacific: Antimicrobial Susceptibility Testing Market, By End-user, 2022-2029 (USD Million)
Table 126 Japan: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 127 Japan: Antimicrobial Susceptibility Testing Consumables Market, By Type, 2022-2029 (USD Million)
Table 128 Japan: Antimicrobial Susceptibility Testing Lab Instruments Market, By Type, 2022-2029 (USD Million)
Table 129 China: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 130 China: Antimicrobial Susceptibility Testing Consumables Market, By Type, 2022-2029 (USD Million)
Table 131 China: Antimicrobial Susceptibility Testing Lab Instruments Market, By Type, 2022-2029 (USD Million)
Table 132 India: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 133 India: Antimicrobial Susceptibility Testing Consumables Market, By Type, 2022-2029 (USD Million)
Table 134 India: Antimicrobial Susceptibility Testing Lab Instruments Market, By Type, 2022-2029 (USD Million)
Table 135 Australia: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 136 Australia: Antimicrobial Susceptibility Testing Consumables Market, By Type, 2022-2029 (USD Million)
Table 137 Australia: Antimicrobial Susceptibility Testing Lab Instruments Market, by Type, 2022-2029 (USD Million)
Table 138 South Korea: List of Conferences on Antimicrobial Activity, 2024
Table 139 South Korea: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 140 South Korea: Antimicrobial Susceptibility Testing Consumables Market, by Type, 2022-2029 (USD Million)
Table 141 South Korea: Antimicrobial Susceptibility Testing Lab Instruments Market, by Type, 2022-2029 (USD Million)
Table 142 Rest of Asia-Pacific: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 143 Rest of Asia-Pacific: Antimicrobial Susceptibility Testing Consumables Market, by Type, 2022-2029 (USD Million)
Table 144 Rest of Asia-Pacific: Antimicrobial Susceptibility Testing Lab Instruments Market, by Type, 2022-2029 (USD Million)
Table 145 Latin America: Macroindicators
Table 146 Latin America: Antimicrobial Susceptibility Testing Market, By Country, 2022-2029 (USD Million)
Table 147 Latin America: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 148 Latin America: Antimicrobial Susceptibility Testing Consumables Market, by Type, 2022-2029 (USD Million)
Table 149 Latin America: Antimicrobial Susceptibility Testing Lab Instruments Market, by Type, 2022-2029 (USD Million)
Table 150 Latin America: Antimicrobial Susceptibility Testing Market, By Type, 2022-2029 (USD Million)
Table 151 Latin America: Antimicrobial Susceptibility Testing Market, By Application, 2022-2029 (USD Million)
Table 152 Latin America: Antimicrobial Susceptibility Testing Market, By Method, 2022-2029 (USD Million)
Table 153 Latin America: Qualitative Antimicrobial Susceptibility Testing Methods Market, by Type, 2022-2029 (USD Million)
Table 154 Latin America: Quantitative Antimicrobial Susceptibility Testing Methods Market, by Type, 2022-2029 (USD Million)
Table 155 Latin America: Antimicrobial Susceptibility Testing Market, By End-user, 2022-2029 (USD Million)
Table 156 Brazil: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 157 Brazil: Antimicrobial Susceptibility Testing Consumables Market, By Type, 2022-2029 (USD Million)
Table 158 Brazil: Antimicrobial Susceptibility Testing Lab Instruments Market, By Type, 2022-2029 (USD Million)
Table 159 Mexico: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 160 Mexico: Antimicrobial Susceptibility Testing Consumables Market, By Type, 2022-2029 (USD Million)
Table 161 Mexico: Antimicrobial Susceptibility Testing Lab Instruments Market, by Type, 2022-2029 (USD Million)
Table 162 Rest of Latin America: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 163 Rest of Latin America: Antimicrobial Susceptibility Testing Consumables Market, by Type, 2022-2029 (USD Million)
Table 164 Rest of Latin America: Antimicrobial Susceptibility Testing Lab Instruments Market, by Type, 2022-2029 (USD Million)
Table 165 Middle East & Africa: Macroindicators
Table 166 Middle East & Africa: Antimicrobial Susceptibility Testing Market, By Region, 2022-2029 (USD Million)
Table 167 Middle East & Africa: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 168 Middle East & Africa: Antimicrobial Susceptibility Testing Consumables Market, by Type, 2022-2029 (USD Million)
Table 169 Middle East & Africa: Antimicrobial Susceptibility Testing Lab Instruments Market, by Type, 2022-2029 (USD Million)
Table 170 Middle East & Africa: Antimicrobial Susceptibility Testing Market, By Type, 2022-2029 (USD Million)
Table 171 Middle East & Africa: Antimicrobial Susceptibility Testing Market, By Application, 2022-2029 (USD Million)
Table 172 Middle East & Africa: Antimicrobial Susceptibility Testing Market, By Method, 2022-2029 (USD Million)
Table 173 Middle East & Africa: Qualitative Antimicrobial Susceptibility Testing Methods Market, by Type, 2022-2029 (USD Million)
Table 174 Middle East & Africa: Quantitative Antimicrobial Susceptibility Testing Methods Market, by Type, 2022-2029 (USD Million)
Table 175 Middle East & Africa: Antimicrobial Susceptibility Testing Market, By End-user, 2022-2029 (USD Million)
Table 176 GCC Countries: Antimicrobial Susceptibility Testing Market, By Product, 2022-2029 (USD Million)
Table 177 GCC Countries: Antimicrobial Susceptibility Testing Consumables Market, by Type, 2022-2029 (USD Million)
Table 178 GCC Countries: Antimicrobial Susceptibility Testing Lab Instruments Market, by Type, 2022-2029 (USD Million)
Table 179 Rest of Middle East & Africa: Antimicrobial Susceptibility Testing Market, by Product, 2022-2029 (USD Million)
Table 180 Rest of Middle East & Africa: Antimicrobial Susceptibility Testing Consumables Market, by Type, 2022-2029 (USD Million)
Table 181 Rest of Middle East & Africa: Antimicrobial Susceptibility Testing Lab Instruments Market, by Type, 2022-2029 (USD Million)
Table 182 Overview of Strategies Adopted by Key Market Players
Table 183 Antimicrobial Susceptibility Market: Degree of Competition
Table 184 Antimicrobial Susceptibility Testing Market: Region Footprint
Table 185 Antimicrobial Susceptibility Testing Market: Product Footprint
Table 186 Antimicrobial Susceptibility Testing Market: Type Footprint
Table 187 Antimicrobial Susceptibility Testing Market: Method Footprint
Table 188 Antimicrobial Susceptibility Testing Market: Application Footprint
Table 189 Antimicrobial Susceptibility Testing Market: End-user Footprint
Table 190 Antimicrobial Susceptibility Market: France Detailed List of Key Startup/SME Players
Table 191 Antimicrobial Susceptibility Market: Competitive Benchmarking Of Key Emerging Players/Startups
Table 192 Antimicrobial Susceptibility Market: Product Launches & Approvals, January 2021- September 2024
Table 193 Antimicrobial Susceptibility Testing Market: Deals, January 2021- September 2024
Table 194 bioMérieux: Company Overview
Table 195 bioMérieux: Products Offered
Table 196 bioMérieux: Product Launches & Approvals, January 2021-September 2024
Table 197 bioMérieux: Deals, January 2021-September 2024
Table 198 Becton, Dickinson and Company: Company Overview
Table 199 Becton, Dickinson and Company: Products Offered
Table 200 Becton, Dickinson and Company: Deals, January 2021-September 2024
Table 201 Becton, Dickinson and Company Other Developments, January 2021-September 2024
Table 202 Thermo Fisher Scientific: Company Overview
Table 203 Thermo Fisher Scientific: Products Offered
Table 204 Thermo Fisher Scientific: Product Launches & Approvals, January 2021-September 2024
Table 205 Thermo Fisher Scientific: Deals, January 2021-September 2024
Table 206 Danaher Corporation: Company Overview
Table 207 Danaher Corporation Products Offered
Table 208 Danaher Corporation: Product Launches & Approvals, January 2021-September 2024
Table 209 Danaher Corporation: Deals, January 2021-September 2024
Table 210 Bio-Rad Laboratories: Company Overview
Table 211 Bio-Rad Laboratories: Products Offered
Table 212 Bio-Rad Laboratories: Deals, January 2021-September 2024
Table 213 Bruker: Company Overview
Table 214 Bruker: Products Offered
Table 215 Bruker: Product Launches & Approvals, January 2021-September 2024
Table 216 Bruker: Deals, January 2021-September 2024
Table 217 Roche Diagnostics: Company Overview
Table 218 Roche Diagnostics Products Offered
Table 219 Roche Diagnostics: Product Launches & Approvals, January 2021-September 2024
Table 220 Roche Diagnostics: Deals, January 2021-September 2024
Table 221 Merck: Company Overview
Table 222 Merck: Products Offered
Table 223 Merck: Deals, January 2021-September 2024
Table 224 Accelerate Diagnostics: Company Overview
Table 225 Accelerate Diagnostics: Products Offered
Table 226 Accelerate Diagnostics: Product Launches & Approvals, January 2021-September 2024
Table 227 Accelerate Diagnostics: Deals, January 2021-September 2024
Table 228 Accelerate Diagnostics: Other Developments, January 2021-September 2024
Table 229 Himedia Laboratories: Company Overview
Table 230 Himedia Laboratories: Products Offered
Table 231 Liofilchem: Company Overview
Table 232 Liofilchem: Products Offered
Table 233 Alifax: Company Overview
Table 234 Alifax: Products Offered
Table 235 Creative Diagnostics: Company Overview
Table 236 Creative Diagnostics: Products Offered
Table 237 Synbiosis: Company Overview
Table 238 Synbiosis: Products Offered
Table 239 Bioanalyse: Company Overview
Table 240 Bioanalyse: Products Offered

Figure 1 Antimicrobial Susceptibility Testing Market Segmentation
Figure 2 Research Design
Figure 3 Antimicrobial Susceptibility Testing Market: Research Design
Figure 4 Key Data from Secondary Sources
Figure 5 Breakdown of Primary Interviews: Supply-Side and Demand-Side Participants
Figure 6 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 7 Research Methodology: Hypothesis Building
Figure 8 Antimicrobial Susceptibility Testing Market Size Estimation: Approach 1 (Company Revenue Estimation)
Figure 9 Antimicrobial Susceptibility Testing Market Size Estimation: Bottom-Up Approach
Figure 10 Antimicrobial Susceptibility Testing Market Size Estimation: End-user Approach
Figure 11 Top-Down Approach
Figure 12 CAGR Projection: Supply-Side Analysis
Figure 13 Data Triangulation Methodology
Figure 14 Antimicrobial Susceptibility Testing Market, By Product, 2024 vs. 2029 (USD Million)
Figure 15 Antimicrobial Susceptibility Testing Market, By Type, 2024 vs. 2029 (USD Million)
Figure 16 Antimicrobial Susceptibility Testing Market, By Application, 2024 vs. 2029 (USD Million)
Figure 17 Antimicrobial Susceptibility Testing Market, By End-user, 2024 vs. 2029 (USD Million)
Figure 18 Geographical Snapshot of Antimicrobial Susceptibility Testing Market
Figure 19 Increasing Research Activities and Advancements in Automated & Molecular Diagnostic Instruments to Drive Market
Figure 20 North American Market to Hold Largest Market Share
Figure 21 Hospitals & Diagnostic Centers Segment Accounted For Largest Market Share in 2023
Figure 22 China to Register Highest Growth Rate During Forecast Period
Figure 23 Antimicrobial Susceptibility Testing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 24 Antimicrobial Susceptibility Testing Market: Ecosystem Analysis
Figure 25 Antimicrobial Susceptibility Testing Market: Supply Chain Analysis
Figure 26 Antimicrobial Susceptibility Testing Market: Value Chain Analysis
Figure 27 Antimicrobial Susceptibility Testing: Porter's Five Forces
Figure 28 Influence of Stakeholders on Buying Process for Top Four End-users
Figure 29 Key Buying Criteria, by End-user
Figure 30 Patent Analysis for Antimicrobial Susceptibility Testing Market (January 2013-December 2023)
Figure 31 Revenue Shift and New Revenue Pockets
Figure 32 Investment and Funding Scenario, 2019-2023
Figure 33 Number of Investor Deals, by Key Player, 2019-2023
Figure 34 Value of Investor Deals, by Key Player, 2018-2022 (USD Million)
Figure 35 Average Selling Price of Ast Products, by Region, 2021-2023 (USD)
Figure 36 Average Selling Price for Top 3 Applications, by Key Player
Figure 37 North America: Antimicrobial Susceptibility Testing Market Snapshot
Figure 38 Asia-Pacific: Antimicrobial Susceptibility Testing Market Snapshot
Figure 39 China: Incidence of Infectious Diseases, 2023
Figure 40 Revenue Analysis of Top Players in Antimicrobial Susceptibility Market, 2019-2023 (USD Million)
Figure 41 Market Share Analysis of Key Players in Antimicrobial Susceptibility Market (2023)
Figure 42 Antimicrobial Susceptibility Market: Company Evaluation Matrix (Key Players), 2023
Figure 43 Antimicrobial Susceptibility Testing Market: Company Footprint
Figure 44 Antimicrobial Susceptibility Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 45 EV/EBITDA of Key Vendors
Figure 46 Year-To-Date (YTD) Price Total Return and 5-Year Stock Beta Of Key Vendors
Figure 47 Antimicrobial Susceptibility Testing Market: Brand/Product Comparative Analysis
Figure 48 bioMérieux: Company Snapshot (2023)
Figure 49 Becton, Dickinson and Company: Company Snapshot
Figure 50 Thermo Fisher Scientific: Company Snapshot
Figure 51 Danaher Corporation: Company Snapshot
Figure 52 Bio-Rad Laboratories: Company Snapshot
Figure 53 Bruker: Company Snapshot
Figure 54 Roche Diagnostics: Company Snapshot
Figure 55 Merck: Company Snapshot
Figure 56 Accelerate Diagnostics: Company Snapshot